Association between peripheral arterial disease and C-reactive protein in the Japanese-Brazilian population

Luciana Garofolo1, Sandra Roberta G Ferreira2, Fausto Miranda Júnior3

  • 1Unversidade Federal de São Paulo, São Paulo, Brazil.

Insights

Peripheral arterial disease (PAD) was not associated with elevated C-reactive protein in Japanese-Brazilians. However, lower ankle-brachial index values correlated with higher C-reactive protein, indicating greater cardiovascular risk.

Area of Science:

  • Cardiovascular Health
  • Epidemiology
  • Biomarkers

Background:

  • Peripheral arterial disease (PAD) is a significant indicator of systemic atherosclerosis.
  • C-reactive protein (CRP) is a marker of inflammation and cardiovascular risk.
  • Understanding the relationship between PAD and CRP in diverse populations is crucial for risk stratification.

Purpose of the Study:

  • To investigate the association between peripheral arterial disease (PAD) and ultrasensitive C-reactive protein (us-CRP) levels.
  • To assess cardiovascular risk factors in the Japanese-Brazilian population.

Main Methods:

  • Cross-sectional study of 1,038 Japanese-Brazilian adults (aged ≥30).
  • Diagnosis of PAD based on ankle-brachial index (ABI) ≤ 0.9.
  • Measurement of ultrasensitive C-reactive protein (us-CRP) levels.

Main Results:

  • Prevalence of PAD was 21%, with no gender difference.
  • No significant association found between PAD and us-CRP levels.
  • Lower ABI (≤ 0.70) correlated with higher us-CRP and poorer cardiometabolic profiles.
  • PAD independently associated with hypertension and smoking.

Conclusions:

  • While PAD and us-CRP were not directly associated, low ABI values indicate elevated inflammation and risk.
  • The findings suggest that ABI severity, rather than PAD presence alone, may correlate with inflammation.
  • This highlights the importance of ABI in identifying high-risk individuals.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
756
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
655
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K